# OnCo record oncopeptides (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/oncopeptides/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "oncopeptides" ;
  schema:name "Oncopeptides"@en ;
  schema:alternateName "Oncopeptides AB"@en ;
  schema:description "Oncopeptides is a Swedish company whose peptide-drug conjugate melflufen (Pepaxto) for relapsed multiple myeloma won accelerated US approval in 2021, was withdrawn there after a survival signal, and remains approved in Europe."@en ;
  schema:url <https://onco.cc/companies/oncopeptides/>, <https://oncopeptides.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://oncopeptides.com>, <https://clinicaltrials.gov/search?lead=Oncopeptides>, <https://en.wikipedia.org/wiki/Oncopeptides> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "SE" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/melflufen/> .